Dechra Pharmaceuticals PLC; Elanco Tiergesundheit AG

The Commission has granted clearance to Dechra Pharmaceuticals PLC, Dechra Limited and Dechra Veterinary Products LLC to acquire the assets, rights and liabilities relating to Osurnia from Elanco Tiergesundheit AG.
  • 26 May 2020


    Decision due

  • 06 May 2020


    Submissions on Statement of Preliminary Issues due

  • 23 Apr 2020


    Statement of Preliminary Issues published

    See documents

  • 26 Mar 2020